Apparatus and method for identifying atrial arrhythmia by far-field sensing

• US 9,522,283 B2
• Filed: 08/27/2015
• Issued: 12/20/2016
• Est. Priority Date: 11/21/2001
• Status: Expired due to Term

• Current Assignee: Cameron Incorporated (Schlumberger NV)
• Original Assignee: Cameron Incorporated (Schlumberger NV)
• Inventors: Bardy, Gust H., Rissmann, William J., Ostroff, Alan H., Erlinger, Paul J., Allavatam, Venugopal
• Primary Examiner(s): GETZOW, SCOTT M
• Application Number:
  US14/838,152
• Publication Number:
  US 20150360040A1
• Time in Patent Office: 481 Days
• US Class Current: 1/1
• CPC Class Codes: A61B 5/349 Detecting specific parameters of the electrocardiograph cycle
• CPC Class Codes: A61B 5/352 Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
• CPC Class Codes: A61B 5/361 Detecting fibrillation
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/3931 Protecting, e.g. back-up systems
• CPC Class Codes: A61N 1/395 for treating atrial fibrillation
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3987 characterised by the timing or triggering of the shock

Abstract

In a subcutaneous implantable cardioverter/defibrillator, cardiac arrhythmias are detected to determine necessary therapeutic action. Cardiac signal information is sensed from far field electrodes implanted in a patient. The sensed cardiac signal information is then amplified and filtered. Parameters such as rate, QRS pulse width, cardiac QRS slew rate, amplitude and stability measures of these parameters from the filtered cardiac signal information are measured, processed and integrated to determine if the cardioverter/defibrillator needs to initiate therapeutic action.

Claims

1. An implantable medical device (IMD) configured for monitoring a patient'"'"'s cardiac rhythm to determine whether an arrhythmia is occurring, the IMD comprising:

a housing containing a battery and operational circuitry for the IMD; and

at least first and second electrodes on the housing and electrically coupled to the operational circuitry, the electrodes configured for sensing a cardiac signal of the patient;

wherein the operational circuitry is configured to detect one or more R-waves for the patient in a sensed cardiac signal from the electrodes and observe whether intervals between consecutive R-waves are consistent or inconsistent;

wherein the operational circuitry is configured to also observe whether a P-wave is present for the patient; and

wherein the operational circuitry is configured to determine that the patient has an atrial arrhythmia in response to determining that the intervals between consecutive R-waves are inconsistent and the P-wave is absent.

2. The implantable medical device of claim 1 wherein the operational circuitry is configured to determine that the patient has a ventricular arrhythmia in response to a determination that the intervals between R-waves are indicative of a rate above a ventricular tachycardia/ventricular fibrillation threshold and to deliver a defibrillation therapy in response to the determination of ventricular arrhythmia.

3. The implantable medical device of claim 2 wherein the operational circuitry is configured to deliver the defibrillation therapy between the first and second electrodes on the housing.

4. The implantable medical device of claim 2 wherein the operational circuitry is configured to perform beat-to-beat morphology analysis and identify a supraventricular tachycardia if the cardiac signal morphology matches from one beat to the next and the intervals between consecutive R-waves are inconsistent.

5. The implantable medical device of claim 2 wherein the operational circuitry is configured to detect the R-waves by analyzing a cardiac signal captured from the electrodes which is band-pass filtered with corners at approximately 10 Hz to approximately 30 Hz.

6. The implantable medical device of claim 2 wherein the operational circuitry is configured to deliver a therapy in response to the identification of atrial arrhythmia by synchronizing a therapy delivery relative to the onset of a QRS signal.

7. The implantable medical device of claim 2 further comprising a three-dimensional accelerometer, wherein the operational circuitry is configured to determine a patient activity level using an output of the accelerometer.

8. The implantable medical device of claim 1 wherein the operational circuitry is configured to perform beat-to-beat morphology analysis and identify a supraventricular tachycardia if the cardiac signal morphology matches from one beat to the next and the intervals between consecutive R-waves are inconsistent.

9. The implantable medical device of claim 1 wherein the operational circuitry is configured to detect the R-waves by analyzing a cardiac signal captured from the electrodes which is band-pass filtered with corners at approximately 10 Hz to approximately 30 Hz.

10. The implantable medical device of claim 1 wherein the operational circuitry is configured for using a far-field signal to record the P-wave.

11. The implantable medical device of claim 10 wherein the operational circuitry is configured to determine that the patient has an atrial arrhythmia by first identifying the P-wave of the patient'"'"'s cardiac signal during a time period of normal sinus rhythm and later determining that the P-wave is replaced by a lower amplitude, variable morphology.

12. The implantable medical device of claim 11 wherein the operational circuitry is configured to observe a timing and amplitude relationship between the P-wave and R-wave of the patient.

13. The implantable medical device of claim 1 wherein the operational circuitry is configured to deliver a therapy in response to the identification of atrial arrhythmia by synchronizing a therapy delivery relative to the onset of a QRS signal.

14. The implantable medical device of claim 1 further comprising a three-dimensional accelerometer, wherein the operational circuitry is configured to determine a patient activity level using an output of the accelerometer.